Mesoblast Limited (MEOBF)
OTHER OTC:MEOBF
Holding MEOBF?
Track your performance easily

Mesoblast Limited (MEOBF) Financial Statements

26 Followers

Mesoblast Limited Financial Overview

Mesoblast Limited's market cap is currently ―. The company's EPS TTM is $-0.089; its P/E ratio is -10.68; Mesoblast Limited is scheduled to report earnings on November 20, 2024, and the estimated EPS forecast is $-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue--$ 1.98M$ 1.44M-
Gross Profit-----
EBIT--$ -19.65M$ -12.39M-
EBITDA--$ -18.57M$ -11.28M-
Net Income Common Stockholders--$ -24.49M$ -16.88M-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 63.18M$ 71.51M$ 67.22M$ 85.11M$ 60.45M
Total Assets$ 669.15M$ 731.33M$ 668.06M$ 684.50M$ 662.14M
Total Debt$ 118.92M$ 116.50M$ 111.78M$ 109.63M$ 106.91M
Net Debt$ 55.74M$ 44.98M$ 44.56M$ 24.52M$ 46.46M
Total Liabilities$ 188.80M$ 167.58M$ 168.06M$ 161.69M$ 165.10M
Stockholders Equity$ 480.36M$ 501.84M$ 500.00M$ 522.81M$ -738.92M
Cash Flow-
Free Cash Flow--$ -16.49M$ -14.49M-
Operating Cash Flow--$ -16.45M$ -14.29M-
Investing Cash Flow--$ -34.00K$ -203.00K-
Financing Cash Flow--$ -2.01M$ 40.30M-
Currency in USD

Mesoblast Limited Earnings and Revenue History

Mesoblast Limited Debt to Assets

Mesoblast Limited Cash Flow

Mesoblast Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis